<SEC-DOCUMENT>0000919574-25-003256-index.html : 20250515
<SEC-HEADER>0000919574-25-003256.hdr.sgml : 20250515
<ACCEPTANCE-DATETIME>20250515162717
ACCESSION NUMBER:		0000919574-25-003256
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250515
DATE AS OF CHANGE:		20250515

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Century Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001850119
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				842040295
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-92725
		FILM NUMBER:		25953923

	BUSINESS ADDRESS:	
		STREET 1:		25 N 38TH STREET, 11TH FLOOR
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104
		BUSINESS PHONE:		215-981-4000

	MAIL ADDRESS:	
		STREET 1:		25 N 38TH STREET, 11TH FLOOR
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Casdin Capital, LLC
		CENTRAL INDEX KEY:			0001534261
		ORGANIZATION NAME:           	
		EIN:				800752351
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		1350 AVENUE OF THE AMERICAS
		STREET 2:		SUITE 2600
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		212.300.5575

	MAIL ADDRESS:	
		STREET 1:		1350 AVENUE OF THE AMERICAS
		STREET 2:		SUITE 2600
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>d11782184_ex99-a.htm
<TEXT>
Document 2 - file: d11782184_ex99-a.htm

</DOCUMENT>
</SEC-DOCUMENT>